Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Travera Inc
National Institutes of Health Clinical Center (CC)
Hoffmann-La Roche
ViroMissile, Inc.
Cancer Research UK
University of Florida
University of Nebraska
Fusion Pharmaceuticals Inc.
Tanabe Pharma America, Inc.
Cancer Research UK
M.D. Anderson Cancer Center
Massive Bio, Inc.
Chongqing Precision Biotech Co., Ltd
Jonsson Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)
Purple Biotech Ltd.
Aminex Therapeutics, Inc.
Taproot Health
Travera Inc
Rain Oncology Inc
UNICANCER
Hoffmann-La Roche
Xencor, Inc.
EMD Serono
Rigshospitalet, Denmark
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Rutgers, The State University of New Jersey